Rheumatoid Arthritis Therapeutics Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2019 – 2025

Report ID: GMI4247

Summary Methodology

Rheumatoid Arthritis Therapeutics Market size is projected to experience significant growth from 2019 to 2025.

Rising incidence of rheumatoid arthritis coupled with growing geriatric population base is driving the market growth. For instance, according to the Centers for Disease Control and Prevention in 2017, in the U.S. an estimated number was announced that is 54.4 million adults suffering from arthritis that covers around 25% of the population.  However, according to the Healthline, around 1.3 million Americans are diagnosed with rheumatoid arthritis.

The growing demand for biologics and increasing penetration of generic drugs coupled with rising number of FDA approvals for the treatment of rheumatoid arthritis is boosting the market growth. For instance, from 2017-2018 FDA approved 2 drugs for the treatment of rheumatoid arthritis. Recently approved biologics such as Kevzara and Xeljanz are expected to boost rheumatoid arthritis therapeutics market growth owing to their strong market penetration and presence of favorable reimbursement scenario.

However, high cost of biologics and accessibility to these biologics may restrict the market growth in the upcoming years.

Biosimilars is expected to witness the lucrative growth over the forecast period. Growing demand for biosimilars in the emerging economies and the availability of these products at the lower price are further boosting the market growth.

North America is currently dominating the rheumatoid arthritis therapeutics market in the region. This is attributed to the couple of factors such as growing prevalence of rheumatoid arthritis patients, strong clinical pipeline, favorable reimbursement policies, high healthcare infrastructure. Moreover, rising healthcare spending and growing approval of novel drugs are some of the factors that are propelling the market growth.

Asia Pacific is expected to witness lucrative growth over the forecast period. This is owing to rising healthcare spending and favorable regulatory policies for biosimilars in the region, that are major key factors contributing to the market growth.

Few of the key companies operating in rheumatoid arthritis therapeutics market include AbbVie, Regeneron Pharmaceuticals, Inc., Novartis International AG,  Pfizer Inc., Bristol-Myers Squibb., Hoffmann-La Roche AG,  Johnson & Johnson, Boehringer Ingelheim GmbH, UCB S.A., and Amgen Inc. Key companies in the market are constantly focusing on the development and launch of novel biologics in order to gain a competitive edge and maintain their position in the market.

Rheumatoid Arthritis Therapeutics Market by Drug Type, 2014-2025 (USD Million)

  • Pharmaceuticals
    • NSAIDs
    • Analgesics
    • DMARDs
    • Glucocorticoids
  • Biopharmaceuticals
    • Biologics
    • Biosimilars

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Russia
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia

Company Profiles:

  • AbbVie
  • Boehringer Ingelheim GmbH
  • Novartis International AG
  • Regeneron Pharmaceuticals, Inc.
  • Pfizer Inc.
  • Bristol-Myers Squibb.
  • Hoffmann-La Roche AG
  • UCB S.A.
  • Johnson & Johnson.
  • Amgen Inc.


What Information does this report contain?

Historical data coverage: 2014 to 2018; Growth Projections: 2019 to 2025.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.

Customize this Report

Pre Book Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Our Market Research Reports Include:

  • Market snapshot
  • Market Segmentation
  • Value Chain Analysis
  • Growth Dynamics
  • Potential Market Opportunities
  • Regulatory Overview
  • Technology Evolution
  • Innovation & Sustainability

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust

  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

GMIPulse Subscription

An interactive business analytics platform; designed to assist clients in accessing and analyzing market data on real-time basis.

Start Your Free Trial
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X